Dana-Farber Cancer Institute

https://www.dana-farber.org/

 

Dana-Farber Cancer Institute
Y

Updates in the Management of SMM/MGUS and the Prevention of Progression

By Dana-Farber Cancer Institute FEATURING Yuxin Liu
By Dana-Farber Cancer Institute FEATURING Yuxin Liu
0 views
July 2, 2024
Comments 0
Login to view comments. Click here to Login

Featured Video

09:36
Johnson & Johnson

Mechanisms of Resistance in Locally Advanced or Metastatic EGFR+ NSC…

Feat. J. Heymach, M. Das

Featured Video

11:12
Stemline

A proven CD123 targeted therapy for BPDCN

Feat. H. Erba
Multiple Myeloma Patient Symposium
26:56
Dana-Farber Cancer Institute

Updates on AL Amyloidosis Treatment: What’s New in 2024

Feat. G. Bianchi
18:51
Dana-Farber Cancer Institute

Multiple Myeloma 101: Diagnosis, Prognosis, and Risk

Feat. P. Richardson
22:45
Dana-Farber Cancer Institute

CAR T-Cells in Multiple Myeloma in 2024

Feat. A. Sperling
19:35
Dana-Farber Cancer Institute

Updates in the Management of SMM/MGUS and the Prevention of Progress…

Feat. Y. Liu
28:37
Dana-Farber Cancer Institute

Bispecific Antibody Therapy in Multiple Myeloma

Feat. S. Midha
35:27
Dana-Farber Cancer Institute

Advances in Multiple Myeloma 2024: From Bench to Bedside

Feat. K. Anderson
24:16
Dana-Farber Cancer Institute

Future of Novel Next Generation Therapy in the Management of R/R MM

Feat. P. Richardson
35:50
Dana-Farber Cancer Institute

Continued Evolution of Therapy for Patients With Newly Diagnosed MM

Feat. C. Mo